Table 1. Indications for pulmonary valve replacement in current guidelines.
European Society of Cardiology
(2010) 77 |
American College of Cardiology/American Heart
Association (2008) 75 |
Canadian Cardiovascular
Society (2009) 76 |
|
---|---|---|---|
Class I | Symptomatic patients with severe PR
and/or PS (RV systolic pressure >60 mm Hg, TR velocity >3.5 m/s) |
Severe PR
and Symptoms or decreased exercise tolerance |
|
Class IIa | Severe PR or PS (or both)
and either: |
Severe PR
and either: |
Free PR
and either: |
RV size | Moderate to severe RV enlargement | EDVi 170 mL/m 2 | |
Progression of
RV size |
Progressive RV dilation | Progressive RV dilation | |
RV function | Progressive RV dysfunction | Moderate to severe RV
dysfunction |
Moderate to severe RV
dysfunction |
TR | Progressive TR, at least moderate | Moderate to severe TR | Important TR |
PS | PS RV systolic pressure greater than
80 mm Hg, TR velocity 4.3 m/s |
Peak instantaneous echocardiography gradient
greater than 50 mm Hg or RV/LV pressure ratio greater than 0.7 or Residual RVOT obstruction (valvular or subvalvular) with progressive and/or severe dilatation of the RV with dysfunction |
RV pressure at least 2/3
systemic pressure |
Exercise
capacity |
Decrease in objective exercise
capacity |
Symptoms such as
deteriorating exercise performance |
|
Arrhythmia | Sustained atrial or ventricular
arrhythmia |
Symptomatic or sustained atrial and/or ventricular
arrhythmias |
Atrial or ventricular
arrhythmia |
EDVi, end-diastolic volume index; LV, left ventricle; PR, pulmonary regurgitation; PS, pulmonary stenosis; RV, right ventricle; RVOT, right ventricle outflow tract; TR, tricuspid regurgitation.